Alternatives to En Carta Diagnostics

Revolutionizing genomic analysis with innovative sequencing technology.

Developing advanced molecular and immunoassay diagnostic solutions for point-of-care testing.

Developing breath-based diagnostics for lung diseases.

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Developing novel immunotherapies and diagnostics for cancer.

AI-powered precision testing for patient identification in clinics and clinical trials.

Cue is a health technology company developing and manufacturing a molecular diagnostic platform for rapid, lab-quality health testing at home.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Developing ultrasound-mediated nonviral genetic medicines.

Pioneering vision restoration therapies for severe retinal degenerations.

Develops nanostructured sensor chips for rapid pathogen identification in food.

Developing AI-powered diagnostics for neurodegenerative diseases.

Developing advanced vision restoration technology through a retinal implant.